Can frailty screening tools predict completion of chemotherapy and chemotherapy toxicity in patients with thoracic malignancy?

J Geriatr Oncol. 2020 Sep;11(7):1154-1156. doi: 10.1016/j.jgo.2020.03.002. Epub 2020 Mar 11.

Authors

Ann Tivey¹, Mohammed Ullah², Alison Beech², Cassandra Ng², Laura Cove-Smith³

Affiliations

¹ The Christie NHS Foundation Trust, United Kingdom; Manchester University NHS Foundation Trust, United Kingdom. Electronic address: [email protected].
² Manchester University NHS Foundation Trust, United Kingdom.
³ The Christie NHS Foundation Trust, United Kingdom; Manchester University NHS Foundation Trust, United Kingdom.

PMID: 32171694
DOI: 10.1016/j.jgo.2020.03.002

No abstract available

Publication types

Letter

MeSH terms

Aged
Frail Elderly
Frailty* / chemically induced
Frailty* / diagnosis
Geriatric Assessment
Humans
Mass Screening
Thoracic Neoplasms* / drug therapy